AWM
ALDX icon

Activest Wealth Management’s Aldeyra Therapeutics ALDX Stock Holding History

Activest Wealth Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9K Buy
15,000
+11,000
+275% +$18.9K 0.01% 347
2026
Q1 		$6.76K Hold
4,000
– – ﹤0.01% 766
2025
Q4 		$20.7K Buy
4,000
+2,000
+100% +$10.3K ﹤0.01% 503
2025
Q3 		$10.4K Hold
2,000
– – ﹤0.01% 497
2025
Q2 		$7.66K Hold
2,000
– – ﹤0.01% 481
2025
Q1 		$11.5K Hold
2,000
– – ﹤0.01% 376
2024
Q4 		$9.98K Hold
2,000
– – ﹤0.01% 316
2024
Q3 		$10.8K Hold
2,000
– – ﹤0.01% 314
2024
Q2 		$6.62K Buy
+2,000
New +$7.83K ﹤0.01% 325

Other funds holding ALDX

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Activest Wealth Management's ALDX Position: Q2 2026 in Review

Activest Wealth Management increased its Aldeyra Therapeutics (ALDX) stake by 275% in Q2 2026, buying an estimated $18.9K and bringing the position to 15,000 shares worth $31.9K. The position accounts for 0.01% of the portfolio, ranked #347.

Activest Wealth Management first reported a position in ALDX in Q2 2024 and has held it in 9 quarters since. 10 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Activest Wealth Management held 15,000 shares of Aldeyra Therapeutics worth $31.9K as of Q2 2026.
  • Activest Wealth Management bought 11,000 Aldeyra Therapeutics shares in Q2 2026, an estimated $18.9K.
  • Aldeyra Therapeutics made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #347 holding.
  • Activest Wealth Management first reported a position in Aldeyra Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 10 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.